Eureka α is Japan's first software as a medical device to
support surgeons' visual recognition in real time
TOKYO, May 2, 2024
/PRNewswire/ -- Anaut Inc., a pioneering developer in
surgical support software led by CEO Dr. Nao Kobayashi, announced regulatory approval of
its groundbreaking medical device, "Eureka α". This
first-of-its-kind software device in Japan received approval from the Ministry of
Health, Labour and Welfare on April 12,
2024 (approval number: 30600BZX00061000) and is set to
transform surgical practices with its advanced artificial
intelligence capabilities.
Innovative Surgical Assistance
Eureka α utilizes state-of-the-art AI to analyze real-time video
from laparoscopic and robotic surgery, enhancing surgeons' accuracy
by highlighting the dissection planes characterized by connective
tissue. Connective tissue, critical in surgical navigation, acts as
a key landmark during surgeries. Known variably as the "dissection
plane" or "holy plane", its proper identification is crucial for
safe and effective surgical outcomes. Visualization of connective
tissue is critical in almost any surgical procedure in the abdomen,
including those that involve the stomach, large intestine, and
abdominal hernias.
Eureka α offers a secondary monitor view that differs from the
primary surgical display to optimize the surgeon's visual field.
Supported by expert-guided training data, the technology harnesses
deep learning and computer vision technologies to improve surgical
precision and safety.
Development and Collaborative Efforts
The development of Eureka α was made possible by a robust
partnership with over 20 of Japan's largest and most prominent academic
research institutions and medical university hospitals. This
initiative has also received backing from significant public
organizations such as the Tokyo Metropolitan Government, the New
Energy and Industrial Technology Development Organization (NEDO),
the Japan External Trade Organization (JETRO), Kawasaki City, and others.
A Leap Forward in Surgical Standards
Japan has long been recognized
for its high safety standards in surgery, aided by technical
accreditation systems and a focus on laparoscopic and
robot-assisted techniques. Eureka α represents a pivotal
advancement in supporting surgical operations, particularly
benefiting young surgeons in mastering complex procedures through
enhanced visual guidance and increased confidence in surgical
performance.
Future Prospects and Global Aspirations
Following the success in Japan
of its flagship product, Surgical Vision Eureka, which is employed
in educational and research settings as a non-medical device, Anaut
Inc. plans to expand the applications of its technology to include
gynecological and urological surgeries. With no equivalent devices
currently approved for clinical use outside of Japan, Eureka α has garnered international
attention, paving the way for expansion into the US and global
markets.
About Anaut Inc.
Founded in July 2020 in
Tokyo, Japan by a team of
surgeons, engineers, and business professionals, Anaut Inc. aims to
merge cutting-edge engineering with surgical expertise to develop
technologies that enhance patient care worldwide, including
decreased complications and higher efficiency. "A
nautical mission in the ocean of anatomy," the company
continues to innovate at the intersection of technology and human
health.
Contact
James Y. Grosvenor
Global Business Development
Anaut Inc.
eureka@anaut-surg.com
Visit our website at https://anaut-surg.com/en/ for further
details.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/anaut-announces-japanese-regulatory-approval-of-ai-powered-surgical-visualization-tool-eureka--302134627.html
SOURCE Anaut Inc.